RO7049389
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for RO7049389, covering 2020-01-10 to 2024-10-31. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7049389 in Healthy Volunteers and Chronic Hepatitis B Virus (HBV) Infected Participants [Phase 1]